Arcturus Therapeutics Holdings (ARCT) Non-Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Non-Current Assets data on file, last reported at $28.5 million in Q1 2026.

• Quarterly Non-Current Assets fell 46.16% year-over-year to $28.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.1 million (down 26.88% YoY) and the FY2025 annual result came in at $29.7 million, down 22.02% from the prior year.
• Non-Current Assets declined to $28.5 million in Q1 2026, from $29.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $64.4 million in Q3 2023 to a low of $15.0 million in Q1 2022.
• A 5-year average of $40.9 million and a median of $42.8 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 322.36% — and 2026, when it plunged 46.16%.
• Tracing ARCT's Non-Current Assets over 5 years: stood at $47.1 million in 2022, then decreased by 9.02% to $42.8 million in 2023, then retreated by 11.03% to $38.1 million in 2024, then dropped by 22.02% to $29.7 million in 2025, then declined by 3.95% to $28.5 million in 2026.
• The last three Non-Current Assets figures came in at $28.5 million (Q1 2026), $29.7 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.